← Back to Search

Behavioural Intervention

Smoking Cessation Intervention (Actify app) for Cancer

Phase 1

Waitlist Available

Led By Jaimee Heffner

Research Sponsored by Fred Hutchinson Cancer Research Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 6 months post-randomization

Awards & highlights

Study Summary

This trial is testing a new smartphone app, Actify, to see if it can help people quit smoking and improve their mood.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 6 months post-randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 6 months post-randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 6 months post-randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Application (App) Utilization

Overall Satisfaction With Assigned Treatment on the Treatment Satisfaction Survey

Secondary outcome measures

Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes

Biochemically Confirmed 7-day PPA From Smoking

Biochemically-confirmed 30-day PPA From Smoking

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (Actify, text notifications)Experimental Treatment3 Interventions

Participants use Actify app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications.

Group II: Arm II (Current Standard Care, text notifications)Active Control3 Interventions

Participants use app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Smoking Cessation Intervention (Actify app)

2022

Completed Phase 1

~250

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Fred Hutchinson Cancer Research CenterLead Sponsor

443 Previous Clinical Trials

148,003 Total Patients Enrolled

Fred Hutchinson Cancer CenterLead Sponsor

556 Previous Clinical Trials

1,343,026 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,464 Previous Clinical Trials

2,618,351 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the Smoking Cessation Intervention (Actify app) received regulatory approval from the FDA?

"The safety of the Smoking cessation Intervention (Actify app) is assessed as a 1 due to this being an early-stage Phase 1 trial, which indicates there is limited data supporting both efficacy and safety."

Answered by AI

Is this experiment recruiting participants currently?

"Clinicaltrials.gov states that this trial, which was initially published on May 9th 2022 and recently edited October 19th 2022, is not currently enrolling patients. However, 11 other studies are actively seeking participants at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation

Jaimee Heffner 2022. "mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04525222.